MiR-125a-5p Decreases the Sensitivity of Treg cells Toward IL-6-Mediated Conversion by Inhibiting IL-6R and STAT3 Expression

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Li, Dan ^a   Kong, Chao ^a,b   Tsun, Andy ^a   Chen, Chen ^a   Song, Huihui ^c   Shi, Guochao ^c   Pan, Wen ^c,d,f   Dai, Dai ^c,d   Shen, Nan ^c,d,e   Li, Bin ^a  

^a INSTITUTE PASTEUR OF SHANGHAI   (China)

^b SHANGHAI UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GATA3 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MICRORNA; MIRN125 MICRORNA, HUMAN; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TRANSCRIPTION FACTOR GATA 3;

GENETICS; HEK293 CELL LINE; HUMAN; JURKAT CELL LINE; METABOLISM; PHYSIOLOGY; REGULATORY T LYMPHOCYTE; RNA INTERFERENCE; UPREGULATION;

GATA3 TRANSCRIPTION FACTOR; HEK293 CELLS; HUMANS; INTERLEUKIN-6; JURKAT CELLS; MICRORNAS; RECEPTORS, INTERLEUKIN-6; RNA INTERFERENCE; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; UP-REGULATION;

EID: 84942876309     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep14615     Document Type: Article

References (50)

1. Sakaguchi, S., Yamaguchi, T., Nomura, T., Ono, M. Regulatory T cells and immune tolerance. Cell 133, 775-787, doi: 10.1016/j. cell.2008.05.009 (2008).
2. Wing, K., Sakaguchi, S. Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat Immunol 11, 7-13, doi: 10.1038/ni.1818 (2010).
3. Koenen, H. J. et al. Human CD25highFoxp3pos regulatory T cells differentiate into IL-17-producing cells. Blood 112, 2340-2352, doi: 10.1182/blood-2008-01-133967 (2008).
4. Zhou, X., Bailey-Bucktrout, S., Jeker, L. T., Bluestone, J. A. Plasticity of CD4(+ ) FoxP3(+ ) T cells. Curr Opin Immunol 21, 281-285, doi: 10.1016/j.coi.2009.05.007 (2009).
5. Sakaguchi, S., Vignali, D. A., Rudensky, A. Y., Niec, R. E., Waldmann, H. The plasticity and stability of regulatory T cells. Nat Rev Immunol 13, 461-467, doi: 10.1038/nri3464 (2013).
6. Kimura, A., Kishimoto, T. IL-6: regulator of Treg/Th17 balance. Eur J Immunol 40, 1830-1835, doi: 10.1002/eji.201040391 (2010).
7. Pasare, C., Medzhitov, R. Toll pathway-dependent blockade of CD4+ CD25+ T cell-mediated suppression by dendritic cells. Science 299, 1033-1036, doi: 10.1126/science.1078231 (2003).
8. Xu, L., Kitani, A., Fuss, I., Strober, W. Cutting edge: regulatory T cells induce CD4+ CD25-Foxp3-T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 178, 6725-6729 (2007).
9. Yang, X. O. et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity 29, 44-56, doi: 10.1016/j.immuni.2008.05.007 (2008).
10. Komatsu, N. et al. Pathogenic conversion of Foxp3(+ ) T cells into TH17 cells in autoimmune arthritis. Nat Med 20, 62-68, doi: 10.1038/nm.3432 (2014).
11. Lal, G. et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J Immunol 182, 259-273 (2009).
12. Gao, Z. et al. Synergy between IL-6 and TGF-beta signaling promotes FOXP3 degradation. Int J Clin Exp Pathol 5, 626-633 (2012).
13. He, L., Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 5, 522-531, doi: 10.1038/nrg1379 (2004).
14. Bartel, D. P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116, 281-297 (2004).
15. Lu, L. F. et al. Function of miR-146a in controlling Treg cell-mediated regulation of Th1 responses. Cell 142, 914-929, doi: 10.1016/j.cell.2010.08.012 (2010).
16. Lu, L. F. et al. Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein. Immunity 30, 80-91, doi: 10.1016/j.immuni.2008.11.010 (2009).
17. Kohlhaas, S. et al. Cutting edge: the Foxp3 target miR-155 contributes to the development of regulatory T cells. J Immunol 182, 2578-2582, doi: 10.4049/jimmunol.0803162 (2009).
18. Abrams, J. T. et al. A clonal CD4-positive T-cell line established from the blood of a patient with Sezary syndrome. J Invest Dermatol 96, 31-37 (1991).
19. Samanta, A. et al. TGF-beta and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3. Proc Natl Acad Sci USA 105, 14023-14027, doi: 10.1073/pnas.0806726105 (2008).
20. Zhang, J. et al. Identification of the E3 deubiquitinase ubiquitin-specific peptidase 21 (USP21) as a positive regulator of the transcription factor GATA3. J Biol Chem 288, 9373-9382, doi: 10.1074/jbc.M112.374744 (2013).
21. Cortez, M. A. et al. miR-29b and miR-125a regulate podoplanin and suppress invasion in glioblastoma. Genes Chromosomes Cancer 49, 981-990, doi: 10.1002/gcc.20808 (2010).
22. Jiang, L., Huang, Q., Chang, J., Wang, E., Qiu, X. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells. Exp Lung Res 37, 387-398, doi: 10.3109/01902148.2010.492068 (2011).
23. Kim, J. K. et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology 57, 1055-1067, doi: 10.1002/hep.26101 (2013).
24. Scott, G. K. et al. Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 282, 1479-1486, doi: 10.1074/jbc.M609383200 (2007).
25. Zhu, W. Y. et al. Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer. Cancer Invest 32, 394-401, doi: 10.3109/07357907.2014.922569 (2014).
26. Garbuzov, A., Tatar, M. Hormonal regulation of Drosophila microRNA let-7 and miR-125 that target innate immunity. Fly (Austin) 4, 306-311 (2010).
27. Chen, T. et al. MicroRNA-125a-5p partly regulates the inflammatory response, lipid uptake, and ORP9 expression in oxLDLstimulated monocyte/macrophages. Cardiovasc Res 83, 131-139, doi: 10.1093/cvr/cvp121 (2009).
28. Potenza, N. et al. Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 39, 5157-5163, doi: 10.1093/nar/gkr067 (2011).
29. Banerjee, S. et al. miR-125a-5p regulates differential activation of macrophages and inflammation. J Biol Chem 288, 35428-35436, doi: 10.1074/jbc.M112.426866 (2013).
30. Rouas, R. et al. Human natural Treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol 39, 1608-1618, doi: 10.1002/eji.200838509 (2009).
31. Fayyad-Kazan, H. et al. Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase. J Biol Chem 285, 20481-20491, doi: 10.1074/jbc.M110.119628 (2010).
32. Rossi, R. L. et al. Distinct microRNA signatures in human lymphocyte subsets and enforcement of the naive state in CD4+ T cells by the microRNA miR-125b. Nat Immunol 12, 796-803, doi: 10.1038/ni.2057 (2011).
33. Ma, L., Teruya-Feldstein, J., Weinberg, R. A. Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449, 682-688, doi: 10.1038/nature06174 (2007).
34. Camps, C. et al. hsa-miR-210 Is induced by hypoxia and is an independent prognostic factor in breast cancer. Clin Cancer Res 14, 1340-1348, doi: 10.1158/1078-0432.CCR-07-1755 (2008).
35. Pulkkinen, K., Malm, T., Turunen, M., Koistinaho, J., Yla-Herttuala, S. Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210. FEBS Lett 582, 2397-2401, doi: 10.1016/j. febslet.2008.05.048 (2008).
36. Zheng, W., Flavell, R. A. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell 89, 587-596 (1997).
37. Zhu, J. et al. Conditional deletion of Gata3 shows its essential function in T(H)1-T(H)2 responses. Nat Immunol 5, 1157-1165, doi: 10.1038/ni1128 (2004).
38. Hosoya, T. et al. GATA-3 is required for early T lineage progenitor development. The Journal of Experimental Medicine 206, 2987-3000, doi: 10.1084/jem.20090934 (2009).
39. Pai, S. Y. et al. Critical roles for transcription factor GATA-3 in thymocyte development. Immunity 19, 863-875 (2003).
40. Wang, L. et al. Distinct functions for the transcription factors GATA-3 and ThPOK during intrathymic differentiation of CD4(+ ) T cells. Nat Immunol 9, 1122-1130, doi: 10.1038/ni.1647 (2008).
41. Wohlfert, E. A. et al. GATA3 controls Foxp3(+ ) regulatory T cell fate during inflammation in mice. J Clin Invest 121, 4503-4515, doi: 10.1172/JCI57456 (2011).
42. Wang, Y., Su, M. A., Wan, Y. Y. An essential role of the transcription factor GATA-3 for the function of regulatory T cells. Immunity 35, 337-348, doi: 10.1016/j.immuni.2011.08.012 (2011).
43. Zheng, S. G., Wang, J., Horwitz, D. A. Cutting edge: Foxp3+ CD4+ CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 180, 7112-7116 (2008).
44. Yao, Z. et al. Nonredundant roles for Stat5a/b in directly regulating Foxp3. Blood 109, 4368-4375, doi: 10.1182/blood-2006-11-055756 (2007).
45. Laurence, A. et al. STAT3 transcription factor promotes instability of nTreg cells and limits generation of iTreg cells during acute murine graft-versus-host disease. Immunity 37, 209-222, doi: 10.1016/j.immuni.2012.05.027 (2012).
46. Iliopoulos, D., Hirsch, H. A., Struhl, K. An epigenetic switch involving NF-kappaB, Lin28, Let-7 MicroRNA, and IL6 links inflammation to cell transformation. Cell 139, 693-706, doi: 10.1016/j.cell.2009.10.014 (2009).
47. Hatziapostolou, M. et al. An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147, 1233-1247, doi: 10.1016/j.cell.2011.10.043 (2011).
48. Liu, S. et al. MicroRNA93 regulates proliferation and differentiation of normal and malignant breast stem cells. PLoS Genet 8, e1002751, doi: 10.1371/journal.pgen.1002751 (2012).
49. Lloyd, C. M., Hawrylowicz, C. M. Regulatory T cells in asthma. Immunity 31, 438-449, doi: 10.1016/j.immuni.2009.08.007 (2009).
50. Zheng, S. G. et al. CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graftversus-host disease with a lupus-like syndrome. J Immunol 172, 1531-1539 (2004).